Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP9386.RAYeBI9wJvP-qjYAJVDowM5Lz3ci5mq9opvkFWkOFjhGU130_assertion description "[Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP9386.RAYeBI9wJvP-qjYAJVDowM5Lz3ci5mq9opvkFWkOFjhGU130_provenance.
• NP9387.RAbqfGF-vwHJqpZ_rtDwJBS7BV_uyPBExtqvevqe5K76E130_assertion description "[Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP9387.RAbqfGF-vwHJqpZ_rtDwJBS7BV_uyPBExtqvevqe5K76E130_provenance.
• NP9347.RAPXg68CR7fOfR_ecdINl7G2a878HhICEFvoJf77UOwe4130_assertion description "[Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP9347.RAPXg68CR7fOfR_ecdINl7G2a878HhICEFvoJf77UOwe4130_provenance.
• NP9345.RAulYRhIObTaBHNCQ3MR7pc7OSmbgenPkj_6IZj-m1h5I130_assertion description "[Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP9345.RAulYRhIObTaBHNCQ3MR7pc7OSmbgenPkj_6IZj-m1h5I130_provenance.
• NP9346.RAnWP1-YczEGdAXn2abRZ5L-ei2RSv5579cZwVXFGkEuc130_assertion description "[Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP9346.RAnWP1-YczEGdAXn2abRZ5L-ei2RSv5579cZwVXFGkEuc130_provenance.
• NP9385.RAnhejRzN9j-3FMmK63yLmCcJmj04IXzKTBf3-GY0ZOwg130_assertion description "[Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP9385.RAnhejRzN9j-3FMmK63yLmCcJmj04IXzKTBf3-GY0ZOwg130_provenance.
• NP661777.RAUf0ymjwwZtmzomAyhGvv2b9xZ1AcHlsKfq06zPzHpto130_assertion description "[Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP661777.RAUf0ymjwwZtmzomAyhGvv2b9xZ1AcHlsKfq06zPzHpto130_provenance.
• NP896528.RARLKANgpeptNIm0zCwhGY3zVAthnIbx-pzuySFAUApb8130_assertion description "[Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP896528.RARLKANgpeptNIm0zCwhGY3zVAthnIbx-pzuySFAUApb8130_provenance.
• NP544045.RAYQuk9Q6SsfFGeZMwMgjeS9AuAsiKChD0MdpuKghVXOc130_assertion description "[Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP544045.RAYQuk9Q6SsfFGeZMwMgjeS9AuAsiKChD0MdpuKghVXOc130_provenance.
• NP7686.RAR_rsR2J4uk-litkf2lV7Z48IJ4nQIIB-9YIvEf4Y9mc130_assertion description "[Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP7686.RAR_rsR2J4uk-litkf2lV7Z48IJ4nQIIB-9YIvEf4Y9mc130_provenance.
• assertion description "[Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP512118.RANtI9MpUQ3_w411h9Avv9IRusC1s826KhlKLzitbjt9I130_assertion description "[Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP512118.RANtI9MpUQ3_w411h9Avv9IRusC1s826KhlKLzitbjt9I130_provenance.
• NP7729.RAAevPb_6HoVPT2CQ0R6aCsiZoU8DOE16-f9Pxj1dQPMc130_assertion description "[Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP7729.RAAevPb_6HoVPT2CQ0R6aCsiZoU8DOE16-f9Pxj1dQPMc130_provenance.
• NP778593.RA800xe8qOCtPpBlN3vf0Pt8vGyxdeaMhOsXeOdQy3z8U130_assertion description "[Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP778593.RA800xe8qOCtPpBlN3vf0Pt8vGyxdeaMhOsXeOdQy3z8U130_provenance.
• NP7728.RA4ehCKRSh4V5Gv5iuCgNduBXVXWnecNVIMYKzzao7CHA130_assertion description "[Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP7728.RA4ehCKRSh4V5Gv5iuCgNduBXVXWnecNVIMYKzzao7CHA130_provenance.
• NP256022.RAz-CBIYMyMQEsEZTzFG9nH3gKLBSlYKn7zEDmrMawD4A130_assertion description "[Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP256022.RAz-CBIYMyMQEsEZTzFG9nH3gKLBSlYKn7zEDmrMawD4A130_provenance.
• NP7685.RAH6YJwXj-umVPWvvGbKgMOWLW7cBtgihcPWvFnq3P0mw130_assertion description "[Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP7685.RAH6YJwXj-umVPWvvGbKgMOWLW7cBtgihcPWvFnq3P0mw130_provenance.
• NP7730.RAKsnEzcEkzLhGMvkfqTP8jp5Q-z5_tojf3iIZokQNFZg130_assertion description "[Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP7730.RAKsnEzcEkzLhGMvkfqTP8jp5Q-z5_tojf3iIZokQNFZg130_provenance.
• NP7683.RAksutR8vWSuE6tCV13rKKGbml4p4vtFVI7egL_TUwFA8130_assertion description "[Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP7683.RAksutR8vWSuE6tCV13rKKGbml4p4vtFVI7egL_TUwFA8130_provenance.
• NP32624.RA8jHe1TAwntGGfUryHIiiTOtiRbxQJ1F4jU-i7o3G5Ok130_assertion description "[Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP32624.RA8jHe1TAwntGGfUryHIiiTOtiRbxQJ1F4jU-i7o3G5Ok130_provenance.
• NP32625.RAQavNj4mGhLGvdtQFLhHHwrEdhkfOioryLqKQuEdczq4130_assertion description "[Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP32625.RAQavNj4mGhLGvdtQFLhHHwrEdhkfOioryLqKQuEdczq4130_provenance.
• NP32629.RAenKjwpR50wRJfg4TybhVfJswcTJnLb57nzDh_zcrh68130_assertion description "[Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP32629.RAenKjwpR50wRJfg4TybhVfJswcTJnLb57nzDh_zcrh68130_provenance.
• NP256309.RAPCHQOQKf_cmSLE2uKpm2aRQGS4kBtovcboAygAR8yho130_assertion description "[Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP256309.RAPCHQOQKf_cmSLE2uKpm2aRQGS4kBtovcboAygAR8yho130_provenance.
• NP256542.RAN-yF4fGYgK_bbF_uwSu0pitt_QnxiU5JtBay74-m6F8130_assertion description "[Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP256542.RAN-yF4fGYgK_bbF_uwSu0pitt_QnxiU5JtBay74-m6F8130_provenance.
• NP32626.RAgPsOB6hiFa_bf22N_v6syInEmLrwOcDXH4ercgxuAaU130_assertion description "[Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP32626.RAgPsOB6hiFa_bf22N_v6syInEmLrwOcDXH4ercgxuAaU130_provenance.
• NP256562.RAmPRNAE8ppi6qd1xNxh0uEAyQbm0D5kZoYyPR5vObGqI130_assertion description "[Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP256562.RAmPRNAE8ppi6qd1xNxh0uEAyQbm0D5kZoYyPR5vObGqI130_provenance.
• NP32627.RAKLzcqsmXIARKQ4cS1Gexk8DDywBKYm0qBU1A7OdLwfM130_assertion description "[Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP32627.RAKLzcqsmXIARKQ4cS1Gexk8DDywBKYm0qBU1A7OdLwfM130_provenance.
• NP32628.RAEb-tYp5cQxe3RNEm8FltFJkrT4Woe4tXITQIXs-IXYA130_assertion description "[Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP32628.RAEb-tYp5cQxe3RNEm8FltFJkrT4Woe4tXITQIXs-IXYA130_provenance.
• NP1053596.RAPMn_YRWUjgfoMtYrXVVK3pR98eWz2RJmzYcl56LMo8E130_assertion description "[Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1053596.RAPMn_YRWUjgfoMtYrXVVK3pR98eWz2RJmzYcl56LMo8E130_provenance.
• NP1053598.RALDRNzq8DIA38AJNDWB0QMr7xVJpCy6ykqw1K4XUW6EI130_assertion description "[Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1053598.RALDRNzq8DIA38AJNDWB0QMr7xVJpCy6ykqw1K4XUW6EI130_provenance.
• NP1053599.RAgY07T0Z8MuggXk8To9OESwOnrldQ-9YLOg-Jmr8P6Ls130_assertion description "[Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1053599.RAgY07T0Z8MuggXk8To9OESwOnrldQ-9YLOg-Jmr8P6Ls130_provenance.
• NP1053600.RAsCI-FrZos7ixIpHYO7l9CQBYW3FZkc-VDAr-vGsv2PA130_assertion description "[Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1053600.RAsCI-FrZos7ixIpHYO7l9CQBYW3FZkc-VDAr-vGsv2PA130_provenance.